This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Faced with declining innovation and increasing financial pressure to reduce R&D expenditures across the board, pharmaceutical companies have realised that the top-down, blockbuster model of drug discovery is no longer viable. Therefore, there is currently a trend in the pharma market of shifting towards a more distributive model for R&D. In order to ensure future revenue growth, the pharmaceutical industry needs to refocus their investment on early drug discovery.

Public-private partnerships where companies form alliances with academic research laboratories have been suggested as the way forward. The advantage of this approach is that the results of drug discovery research would be made publicly available for everyone to see. The advantage of this approach is that the results of drug discovery research would be publicly available for everyone to see. This would leverage the expertise of global academia with the potential to arrive at therapies more quickly.

What Questions Should You Ask before Buying a Market Research Report?
  • How is the drug discovery outsourcing market evolving?
  • What is driving and restraining the drug discovery outsourcing market?
  • How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each drug discovery outsourcing submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading drug discovery outsourcing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the drug discovery outsourcing projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033?
  • What are the implications of drug discovery outsourcing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the drug discovery outsourcing market?
  • Where is the drug discovery outsourcing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the drug discovery outsourcing market today, and over the next 10 years:
  • Our 389-page report provides 134 tables and 186 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the drug discovery outsourcing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Service Type
  • Chemistry Services
  • Biology Services

Workflow
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Other Associated Workflow

Therapeutic Area
  • Oncology
  • Infectious Disease
  • Central Nervous System
  • Immunology
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Others

Molecule Type
  • Large Molecules
  • Small Molecules

End-users
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Others